Literature DB >> 31555561

Fournier's gangrene: a modern analysis of predictors of outcomes.

Jeffrey D Sparenborg1, Jacob A Brems1, Andrew M Wood2, Jonathan J Hwang3, Krishnan Venkatesan3.   

Abstract

BACKGROUND: Fournier's gangrene (FG) is a rapidly progressing necrotizing fasciitis that carries a significant morbidity and mortality. The present study sought to identify the predisposing factors related to FG and validate the Fournier's Gangrene Severity Index (FGSI) score as a prognostic tool in the care of the Fournier's patient.
METHODS: Medstar Washington Hospital Center records were searched from January 2003 to February 2015 for all patients with a diagnosis code of FG, n=42. Epidemiologic data was collected for patients and used to calculate an FGSI score.
RESULTS: The average age was 53.45 yrs and M/F ratio was 39:1. Patients presented with an average 2.675 predisposing factors; the most common was diabetes mellitus (n=21) followed by hypertension (n=18). The most common etiology was periscrotal (n=25) next to perirectal (n=9). Streptococcus was the most common source of infection (n=14). Patients on average required three surgical interventions. The average and median hospitalization period was 19.625 and 11.5 days respectively. Eleven patients developed sepsis. Twenty-four (60%) patients experienced a complication. The overall mortality was 5% (n=2). The average FGSI on admission was 5.368. Multivariate analysis showed FGSI score correlates with more surgical intervention, longer hospitalization, sepsis, complication and mortality.
CONCLUSIONS: The FGSI score predicts a greater likelihood of more surgical interventions, longer hospitalization period, sepsis, complications and mortality within this patient population. Diabetes mellitus continues to be the most common predisposing factors in FG patients. The mortality rate of 5% is much less than the historically reported 20-30% and may reflect improved understanding and care of this aggressive disease.

Entities:  

Keywords:  Fournier’s gangrene (FG); morbidity; mortality; outcomes

Year:  2019        PMID: 31555561      PMCID: PMC6732100          DOI: 10.21037/tau.2019.03.09

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


  23 in total

1.  Fournier's gangrene: overview of prognostic factors and definition of new prognostic parameter.

Authors:  Bulent Erol; Altug Tuncel; Volkan Hanci; Husnu Tokgoz; Abdulkadir Yildiz; Bulent Akduman; Eksal Kargi; Aydin Mungan
Journal:  Urology       Date:  2010-05       Impact factor: 2.649

2.  Fournier's gangrene: etiology and outcome analysis of 41 patients.

Authors:  Silvio Altarac; Davorin Katušin; Suad Crnica; Dino Papeš; Zoran Rajković; Nuhi Arslani
Journal:  Urol Int       Date:  2012-03-14       Impact factor: 2.089

3.  Fournier's gangrene: an analysis of 80 patients and a novel scoring system.

Authors:  T Yilmazlar; E Ozturk; H Ozguc; I Ercan; H Vuruskan; B Oktay
Journal:  Tech Coloproctol       Date:  2010-06-18       Impact factor: 3.781

4.  Is there a need for the Fournier's gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier's gangrene.

Authors:  Florian Roghmann; Christian von Bodman; Björn Löppenberg; Andreas Hinkel; Jüri Palisaar; Joachim Noldus
Journal:  BJU Int       Date:  2012-04-11       Impact factor: 5.588

5.  Fournier's gangrene: management and mortality predictors in a population based study.

Authors:  Mathew D Sorensen; John N Krieger; Frederick P Rivara; Matthew B Klein; Hunter Wessells
Journal:  J Urol       Date:  2009-10-17       Impact factor: 7.450

6.  Causes, presentation and survival of fifty-seven patients with necrotizing fasciitis of the male genitalia.

Authors:  M D Clayton; J E Fowler; R Sharifi; R K Pearl
Journal:  Surg Gynecol Obstet       Date:  1990-01

7.  Evaluation of a severity score to predict the prognosis of Fournier's gangrene.

Authors:  Saturnino Luján Marco; Alberto Budía; Carlos Di Capua; Enrique Broseta; Fernando Jiménez Cruz
Journal:  BJU Int       Date:  2009-11-17       Impact factor: 5.588

8.  Fournier's gangrene: evaluation of 68 patients and analysis of prognostic variables.

Authors:  H R Unalp; E Kamer; H Derici; K Atahan; U Balci; C Demirdoven; O Nazli; M A Onal
Journal:  J Postgrad Med       Date:  2008 Apr-Jun       Impact factor: 1.476

9.  Validation of the Fournier's gangrene severity index in a large contemporary series.

Authors:  A T Corcoran; M C Smaldone; E P Gibbons; T J Walsh; B J Davies
Journal:  J Urol       Date:  2008-07-17       Impact factor: 7.450

10.  Fournier's gangrene: ten-year experience in a medical center in northern Taiwan.

Authors:  Chen-Feng Kuo; Wei-Sheng Wang; Chun-Ming Lee; Chang-Pan Liu; Hsiang-Kuang Tseng
Journal:  J Microbiol Immunol Infect       Date:  2007-12       Impact factor: 4.399

View more
  2 in total

Review 1.  The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review.

Authors:  John P H Wilding; Marc Evans; Kevin Fernando; Jose Luis Gorriz; Ana Cebrian; Jane Diggle; Debbie Hicks; June James; Philip Newland-Jones; Amar Ali; Stephen Bain; Andrea Da Porto; Dipesh Patel; Adie Viljoen; David C Wheeler; Stefano Del Prato
Journal:  Diabetes Ther       Date:  2022-03-20       Impact factor: 3.595

2.  Management of Fournier's gangrene during the Covid-19 pandemic era: make a virtue out of necessity.

Authors:  Alessio Paladini; Giovanni Cochetti; Angelica Tancredi; Matteo Mearini; Andrea Vitale; Francesca Pastore; Paolo Mangione; Ettore Mearini
Journal:  Basic Clin Androl       Date:  2022-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.